Discontinued — last reported Q3 '23
UnitedHealth Group Interest Paid remained flat by 0.0% to $1.01B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.1%, from $898.50M to $1.01B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 25.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.65B | $1.95B | $3.04B | $3.59B | $4.03B |
| YoY Change | — | +17.7% | +56.0% | +18.4% | +12.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.